432 filings
6-K
IPCIF
Intellipharmaceutics International Inc.
14 Jun 24
Intellipharmaceutics Announces Downgrade to OTC Expert Market
4:47pm
NT 20-F
IPCIF
Intellipharmaceutics International Inc.
2 Apr 24
Notice of late annual filing (foreign)
9:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
13 Mar 24
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
8:06pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Mar 24
Intellipharmaceutics Announces Cease Trade Order
3:21pm
6-K
IPCIF
Intellipharmaceutics International Inc.
26 Feb 24
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
9:11pm
UPLOAD
2wj2hqy4rgc 8eo2ba
14 Feb 24
Letter from SEC
12:00am
6-K
suxb1r
9 Feb 24
Intellipharmaceutics International Inc. Announces Stock Option Grant
12:00am
20-F/A
xdlmjawf iik
6 Feb 24
Annual report (foreign) (amended)
12:00am
6-K
yvimi4mig fxfx
11 Jan 24
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
6:14pm
6-K
4mbnqoafarnq52
16 Oct 23
Current report (foreign)
5:23pm
6-K
x205ejb91 ex6a2x5
6 Oct 23
Annual Meeting of Shareholders
11:33am
6-K
xnrcjptqj8o2 k1mc4a
6 Oct 23
Intellipharmaceutics Reports Director Election Results
11:33am
6-K
ao8ubheusvjgg
26 Sep 23
Current report (foreign)
5:29pm
6-K
1edzgpq 3zaomi4n
26 Sep 23
Current report (foreign)
5:23pm
6-K
p68oxxdl6haxj 87yuku
14 Oct 22
Current report (foreign)
4:22pm
6-K
tpowgb0ucpbpccfxqjf
21 Jul 22
Current report (foreign)
5:28pm
6-K
w52y05 aese
15 Jul 22
Primary Document
8:05am
6-K
jr5sim
27 May 22
Intellipharmaceutics Reports Director Election Results
4:49pm
20-F/A
7b2fl56
6 May 22
Annual report (foreign) (amended)
7:54pm